INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $35,000 | – | 20,835 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 126,007 | $58,000 | 0.01% |
| IMS Capital Management | 20,146 | $9,000 | 0.01% |
| VANGUARD GROUP INC | 577,440 | $263,000 | 0.00% |
| JANE STREET GROUP, LLC | 46,799 | $21,000 | 0.00% |
| EATON VANCE MANAGEMENT | 2 | $0 | 0.00% |
| UBS Group AG | 12,659 | $6,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 108 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 70 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 210 | $0 | 0.00% |